iShares Biotechnology ETF $IBB Stake Reduced by Apollon Wealth Management LLC

Apollon Wealth Management LLC lessened its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 2.7% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 8,518 shares of the financial services provider’s stock after selling 236 shares during the period. Apollon Wealth Management LLC’s holdings in iShares Biotechnology ETF were worth $1,078,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently bought and sold shares of the stock. Trust Co. of Toledo NA OH acquired a new stake in iShares Biotechnology ETF during the 2nd quarter worth about $32,000. Vontobel Holding Ltd. raised its holdings in iShares Biotechnology ETF by 6.7% during the 2nd quarter. Vontobel Holding Ltd. now owns 5,464 shares of the financial services provider’s stock worth $691,000 after buying an additional 341 shares during the period. Rye Brook Capital LLC raised its holdings in iShares Biotechnology ETF by 13.0% during the 2nd quarter. Rye Brook Capital LLC now owns 24,300 shares of the financial services provider’s stock worth $3,074,000 after buying an additional 2,800 shares during the period. Massachusetts Wealth Management raised its holdings in iShares Biotechnology ETF by 12.6% during the 2nd quarter. Massachusetts Wealth Management now owns 2,803 shares of the financial services provider’s stock worth $355,000 after buying an additional 313 shares during the period. Finally, Bar Harbor Wealth Management raised its holdings in iShares Biotechnology ETF by 1.8% during the 2nd quarter. Bar Harbor Wealth Management now owns 15,568 shares of the financial services provider’s stock worth $1,970,000 after buying an additional 276 shares during the period. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

NASDAQ IBB opened at $151.32 on Wednesday. The stock’s 50-day moving average price is $141.61 and its two-hundred day moving average price is $130.87. iShares Biotechnology ETF has a 1 year low of $107.43 and a 1 year high of $153.01.

iShares Biotechnology ETF Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, September 19th. Shareholders of record on Tuesday, September 16th were paid a dividend of $0.0828 per share. This represents a $0.33 annualized dividend and a yield of 0.2%. The ex-dividend date of this dividend was Tuesday, September 16th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.